05 Compliance

Where L-cysteine HCl is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-20 · L-Cysteine HCl

On this page
  1. The four checks
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Claims and labelling
  6. The document pack
  7. What to check before the first order

L-cysteine hydrochloride sits on two different routes in the EU: E 920, the flour-treatment additive, and the supplement ingredient, which is not harmonised and depends on Member State law. In the US, L-cysteine has a GRAS entry for dough strengthening and a dietary-supplement route for the amino acid. The UK applies retained law in Great Britain and the EU regime in Northern Ireland. The file has to name the route and the form.

In one line

The additive entry and the supplement entry are two different routes, and the L-cysteine file has to name which one the destination market uses.

The four checks

Selling an L-cysteine HCl lot raises four questions that are often conflated: is the substance permitted, and on which route; which contaminant ceiling applies at the daily dose; does the label declare the form and the hydrate correctly; and is the statement an authorised claim, a structure/function statement, or not allowed at all? The answers do not travel together. A flour-treatment entry is not a supplement authorisation, and a supplement route in one Member State is not a route in another.

The form matters twice. The additive definition covers the hydrochloride and its monohydrate; the supplement file has to name the same hydrate that the certificate reports. The buyer's regulatory team confirms the destination route, and this page lists the documents and checks that belong in the file. Check the current text before relying on any date here.

European Union

Directive 2002/46/EC harmonises food supplements for vitamins and minerals; its Annex I and Annex II list those substances, not amino acids. L-cysteine as a supplement ingredient is therefore regulated mainly through Member State law and the general food rules, including the food–medicine borderline. Member States differ on which amino acids and doses they accept, so the destination country is the first check, not the last.

The additive route is separate. Regulation (EC) No 1333/2008 and its implementing list in Regulation (EU) No 1129/2011 authorise E 920, L-cysteine, as a flour-treatment agent at quantum satis in the bakery uses listed. Commission Regulation (EU) No 231/2012 defines E 920 as L-cysteine hydrochloride or hydrochloride monohydrate and states that human hair may not be used as a source. That entry covers the additive use; it does not authorise a supplement dose, and it does not settle the supplement route in a given Member State.

Labelling follows Regulation (EU) No 1169/2011 and the supplement particulars in Directive 2002/46/EC; claims follow Regulation (EC) No 1924/2006. The EU regulatory note collects the framework references.

United States

In the US, 21 CFR 184.1271 lists L-cysteine as GRAS for use as a dough strengthener in yeast-leavened baked goods, at up to 0.009 part of total L-cysteine per 100 parts of flour in dough. That regulation covers a food use. A supplement relies on the amino acid as a dietary ingredient, and the label follows the Supplement Facts panel in 21 CFR 101.36.

L-cysteine has no Daily Value, so the panel declares the amount per serving without a percentage. A structure/function statement must be truthful, not misleading and substantiated, and must sit beside the DSHEA disclaimer under 21 CFR 101.93. There is no federal maximum for lead in supplements; state law can add one, and California's Proposition 65 sets a maximum allowable dose level of 0.5 µg/day for lead. The US regulatory note sets out the framework.

Contaminants and limits

The contaminant panel is a finished-product calculation, not only a drum result. The table is the usual starting point for a food-supplement file; the destination text and the daily dose decide the final limit.

Contaminant limits to confirm for the finished product
ParameterTypical supplement referenceWhat the file should show
Lead (Pb)3.0 mg/kg in the supplementLot result, method, limit and the finished-product calculation
Cadmium (Cd)1.0 mg/kg in the supplementLot result and any category exception
Mercury (Hg)0.10 mg/kg in the supplementLot result and method
Arsenic (As)No harmonised EU number; the buyer sets oneThe agreed limit and the method on the certificate

The catalog raw-material gate is Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. Whether that gate is adequate depends on the dose and on the share of the formula; a raw-material result cannot be pasted onto the finished label.

Claims and labelling

The EU claim register under Regulation (EC) No 432/2012 authorises only the listed wording and conditions. No L-cysteine claim appears there as of this review, and L-cysteine has no EU nutrient reference value to anchor a “source of” nutrition claim. In the US, a structure/function statement is written and substantiated by the brand and carries the DSHEA disclaimer; it is not an FDA approval and cannot describe a disease or a medicinal use. In the UK, the GB nutrition and health claims register performs the same role, and no L-cysteine claim appears there as of this review.

The label should name the form and the hydrate: L-cysteine hydrochloride monohydrate, not “L-cysteine” or an abbreviation alone. A product that also contains NAC or L-cystine must declare each form separately. Nothing on this page is a claim for the ingredient.

The document pack

A complete lot file usually contains:

  • A lot COA with assay by titration and its basis, specific rotation with conditions, infrared and titration identity, water, chloride, mesh, metals and microbiology.
  • A TDS, a purchase specification naming the form, hydrate and mesh, and a 16-section SDS.
  • Allergen, GMO, origin, residual-solvent and animal-derived input statements.
  • An elemental-impurity report against the destination limit at the intended dose.
  • Stability data for the grade and pack, and the storage condition on the TDS.
  • An EU market note recording the additive and supplement routes, and an independent COA where required.

The source statement is not boilerplate. The E 920 definition excludes human hair as a source for the additive, and the supplement file should record whether the lot comes from hydrolysis, enzymatic synthesis or fermentation. The COA page shows the parameters the file has to support, and the identity page explains how the form is proved.

What to check before the first order

  1. Which market will sell the product, and which route is documented there?
  2. Does the COA name the salt and the hydrate, and report rotation and chloride, not only the assay?
  3. Are the metal figures below the destination ceiling at the actual daily dose?
  4. Does the label name the form and the hydrate, and avoid an NRV it does not have?
  5. Is every claim inside the authorised wording or a properly disclaimed structure/function statement?
  6. Is the lot file complete and lot-coded, with the additive and supplement routes recorded separately?

The product hub carries the catalog specification, the quality page describes how the lot file is assembled, and the MOQ page covers the pack and the quotation.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation